BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 21, 2013
View Archived Issues
Velocity Pharmaceutical Development announces collaboration and VPD-737 IND
Read More
Tyrosine-protein kinase inhibitors disclosed by Daiichi Sankyo
Read More
Novel Bcl-2 inhibitors reported by French researchers
Read More
Ambra-1 expression is linked to NRAS/BRAF mutational status in melanoma
Read More
MacroGenics doses first patient in phase I MGA-271 trial
Read More
OSI Pharmaceuticals presents new compounds with promise in ovarian cancer models
Read More
BYM-338 receives FDA breakthrough therapy designation
Read More
Adimab establishes new collaborations with Innovent and Celgene
Read More
Varinel synthesizes novel iron chelators for neurodegenerative disorders
Read More
Novel hRAD51 protein expression inhibitors disclosed by Eisai
Read More
Otonomy's OTO-201 reduces treatment failure in subjects undergoing ear tube placement surgery
Read More
Toray Industries divulges new SEH inhibitors for hypertension
Read More
DiaMedica enrolls final patient in DM-199 clinical trial
Read More
Eisai files petition in federal court seeking DEA scheduling of Fycompa
Read More
FDA grants orphan drug designation to Alnylam's RNAi therapeutic for hemophilia A
Read More
RedHill completes European regulatory meetings for Crohn's disease therapeutic
Read More
Mutations in TGF-beta predispose to allergic phenotypes in humans
Read More
Oncopeptides commences phase II study of melflufen in multiple myeloma
Read More
PDI signs agreement to commercialize molecular diagnostic tests
Read More
Membrane active chelators for the treatment of malaria and African trypanosomiasis
Read More
FDA grants orphan drug status to dantrolene sodium
Read More
Australian team prepares new L-type calcium channel compounds
Read More
Orphan drug status granted to deflazacort
Read More
FDA grants orphan drug status for ruxolitinib
Read More